3 completed. 3 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 1 | 2 | Completed 2 |
Follow BPGbio: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| BPM31510 Administered Intravenously With Gemcitabine in Advanced Pancreatic Cancer Patients BPM31510 Nanosuspension Injection, Gemcitabine - Pancreatic Cancer | Phase 2 | Completed | BPGbio | 45 | 2016-07-06 | 2025-03-26 |
| An Open-Label Safety Study of API 31510 in a Topical Cream for in Situ Cutaneous Squamous Cell Carcinoma (SCCIS) API 31510 - Squamous Cell Carcinoma | Phase 1 / Phase 2 | Completed | BPGbio | 35 | 2008-06-01 | 2019-03-05 |
| Dose-Ranging Clinical Trial of Topical Creams Containing API 31510 for the Treatment of Superficial Basal Cell Carcinoma API 31510 3% Topical Cream, API 31510 1.5% Topical Cream, Placebo - Superficial Basal Cell Carcinoma | Phase 1 / Phase 2 | Completed | BPGbio | 186 | 2008-03-01 | 2025-02-28 |
Carcinoma, Squamous Cell (1) · Neoplasms (1) · Pancreatic Neoplasms (1)
Gemcitabine (1) · coenzyme Q10 (1)
United States (3) · United Kingdom (1)
David Wilson, MD (1) · Ramesh K Ramanathan, MD (1)